Gene · 6196
Papers2,567
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 2,567
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer. | Front Immunol | 2022 | 36479114 | PubTator, text mining | PubMed |
| A novel thinking: DDR axis refines the classification of ccRCC with distinctive prognosis, multi omics landscape and management strategy. | Front Public Health | 2022 | 36478716 | PubTator, text mining | PubMed |
| Licorice (Glycyrrhiza glabra L.)-Derived Phytochemicals Target Multiple Signaling Pathways to Confer Oncopreventive and Oncotherapeutic Effects. | Onco Targets Ther | 2022 | 36474507 | PubTator, text mining | PubMed |
| Genome-wide differential DNA methylation analysis of MDA-MB-231 breast cancer cells treated with curcumin derivatives, ST08 and ST09. | BMC Genomics | 2022 | 36474139 | PubTator, text mining | PubMed |
| Complexity of progranulin mechanisms of action in mesothelioma. | J Exp Clin Cancer Res | 2022 | 36471440 | PubTator, text mining | PubMed |
| Combined bulk RNA-seq and single-cell RNA-seq identifies a necroptosis-related prognostic signature associated with inhibitory immune microenvironment in glioma. | Front Immunol | 2022 | 36466844 | PubTator, text mining | PubMed |
| ERK-mediated NELF-A phosphorylation promotes transcription elongation of immediate-early genes by releasing promoter-proximal pausing of RNA polymerase II. | Nat Commun | 2022 | 36463234 | PubTator, text mining | PubMed |
| Defective synaptic plasticity in a model of Coffin-Lowry syndrome is rescued by simultaneously targeting PKA and MAPK pathways. | Learn Mem | 2022 | 36446603 | PubTator, text mining | PubMed |
| Next Generation Sequencing of Reactive Stroma and Residual Breast Cancer Cells in Tumor Bed after Neoadjuvant Chemotherapy. | Cancers (Basel) | 2022 | 36428702 | PubTator, text mining | PubMed |
| Insights from the protein sequence and structure analysis of PgHsc70 and OsHsp70 genes. | Bioinformation | 2022 | 36420430 | PubTator, text mining | PubMed |
| Adenoid cystic carcinoma of the Bartholin's gland is easily misdiagnosed: A case report and literature review. | Medicine (Baltimore) | 2022 | 36397326 | PubTator, text mining | PubMed |
| Recent progress in epigenetics of obesity. | Diabetol Metab Syndr | 2022 | 36397166 | PubTator, text mining | PubMed |
| Upregulation of ATF4-LAMP3 Axis by ORF45 Facilitates Lytic Replication of Kaposi's Sarcoma-Associated Herpesvirus. | J Virol | 2022 | 36377873 | PubTator, text mining | PubMed |
| Ts66Yah, a mouse model of Down syndrome with improved construct and face validity. | Dis Model Mech | 2022 | 36374158 | PubTator, text mining | PubMed |
| Influence of Anodizing Parameters on Tribological Properties and Wettability of Al2O3 Layers Produced on the EN AW-5251 Aluminum Alloy. | Materials (Basel) | 2022 | 36363325 | PubTator, text mining | PubMed |
| POLDIP3: At the Crossroad of RNA and DNA Metabolism. | Genes (Basel) | 2022 | 36360158 | PubTator, text mining | PubMed |
| Inhibition of BRD4 enhanced the tumor suppression effect of dasatinib in gastric cancer. | Med Oncol | 2022 | 36352160 | PubTator, text mining | PubMed |
| Major pathways involved in macrophage polarization in cancer. | Front Immunol | 2022 | 36325334 | PubTator, text mining | PubMed |
| Potential role of autophagy induced by FLT3-ITD and acid ceramidase in acute myeloid leukemia chemo-resistance: new insights. | Cell Commun Signal | 2022 | 36316776 | PubTator, text mining | PubMed |
| Depletion of PARP10 inhibits the growth and metastatic potential of oral squamous cell carcinoma. | Front Genet | 2022 | 36313419 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6196/papers?page=19